HOME Top Market Reports Clinical Trial Management System Market by End-user (Pharmaceutical & Biotechnology, Medical Device Companies, CROs), Delivery Mode (Web Hosted, On-premise, Cloud-based), Type (Enterprise, Site), Component (Software, Service) - Global Forecast to 2021

Clinical Trial Management System Market by End-user (Pharmaceutical & Biotechnology, Medical Device Companies, CROs), Delivery Mode (Web Hosted, On-premise, Cloud-based), Type (Enterprise, Site), Component (Software, Service) - Global Forecast to 2021

By: marketsandmarkets.com
Publishing Date: August 2016
Report Code: HIT 1686

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The clinical trial management system (CTMS) market is expected to reach USD 920.2 Million by 2021, at a CAGR of 11.5% during the forecast period. Increasing adoption of software solutions (including CTMS) during clinical trials, increasing number of clinical trials, and rising R&D expenditure of pharma and biopharma companies are some of the key factors driving the growth of this market. Furthermore, increasing outsourcing of clinical trials to CROs in Asian countries is further aiding to the growth prospects of this market.

However, lack of skilled professionals for handling sophisticated CTMS solutions in research and budget constraints faced by start-ups and small-medium sized companies in life science industry can hinder the growth of this market.

CROs; medical device, pharma and biotechnology companies use CTMS to plan, track, manage clinical trials and their progress. Increasing R&D expenditure of major end-user of CTMS- life science and clinical research organizations stimulates the adoption of CTMS solutions during clinical trials, which in turn is driving the growth of the market. It is estimated that currently global pharma industry spends ~USD 130 to 150 billion annually on R&D and this number is expected to grow ~16% by 2020 (Source: Icon plc and Catalent Pharma Solutions). Likewise, the R&D expenditure of the Pharmaceutical Research and Manufacturers of America (PhRMA) member companies in the U.S. increased from ~USD 26.0 Billion in 2000 to USD 58.8 billion in 2015. In addition, the number of medicines under development in the U.S. witnessed an increase of 40% from 2005 to 2013 (Source: Pharmaceutical Research and Manufacturers of America).

The global rise in the number of clinical trials is directly contributing to the increase in demand of CTMS solutions. As per ClinicalTrials.gov, 182,957 clinical trials were registered across the globe in 2014; this number increased by 13.0% to 206,900 trials in 2015. Asian countries are emerging as key outsourcing destinations for clinical trials, as a significant number of clinical trials are outsourced to CROs based out of Asian countries (primarily Japan, China, and India). According to database from clinicaltrials.gov, in October 2012, ~15.3% of the world’s clinical trials were being carried out in Asian counties, and this ratio increased to over 17.2% by June 2016.

This report broadly segments the global CTMS market into type, delivery mode, end-user, and component. The CTMS market by type is segmented into Enterprise CTMS and Site CTMS. The CTMS market by delivery mode is segmented into Web-Based (Hosted) CTMS, Licensed Enterprise (On Premise) CTMS and Cloud-Based (SaaS) CTMS. The cloud-based CTMS solutions segment is projected to grow at the highest CAGR in the next five years. The CTMS market by component, is segmented into software and services. The CTMS market by end-users, is segmented into pharmaceutical and biopharmaceutical companies, contract research organizations, medical device companies and others. The Pharmaceutical and biopharmaceutical companies segment commanded is expected to account for the largest share of the global CTMS market in 2016.

Geographically, the global CTMS market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, North America commanded a major share of the CTMS market. However, Asia-Pacific is expected to witness the highest growth rate during the forecast period. Growth in the Asia-Pacific market can be attributed to the increase in outsourcing of clinical trials, availability of large and diverse patient population, and presence of less stringent regulatory guidelines as compared to developed nations in the region.

Oracle Corporation (U.S.), Medidata Solutions, Inc. (U.S.), PAREXEL International Corporation (U.S.), BioClinica, Inc. (U.S.) and Bio-Optronics, Inc. (U.S.), ERT (U.S.), Merge Healthcare Incorporated (U.S.), eClinforce (U.S.), DATATRAK International Inc. (U.S.), VEEVA SYSTEMS, INC. (U.S.), DSG Inc. (U.S.), Forte Research Systems, Inc. (U.S.), and MedNet Solutions, Inc. (U.S.) are some of the key players in the CTMS market.

Target Audience:

  • Healthcare IT Service Providers
  • eClinical Solution Vendors
  • Clinical Research Organizations
  • Pharmaceutical/Biopharmaceutical Companies
  • Research and Development (R&D) Companies
  • Business Research and Consulting Service Providers
  • Medical Research Laboratories
  • Academic Medical Centers/Universities/Hospitals

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report

This research report categorizes the CTMS market into the following segments and sub segments:

Global CTMS Market, by End User

  • Pharmaceutical and Biopharmaceutical Companies
  • Contract Research organizations
  • Medical Device Companies
  • Others*

Note: The other end-user segment include hospitals and academic research institutes

Global CTMS Market, by Delivery Mode

  • Web-Based (Hosted) CTMS
  • Licensed Enterprise (On Premise) CTMS
  • Cloud-Based (SaaS) CTMS

Global CTMS Market, by Type

  • Enterprise CTMS
  • Site CTMS

Global CTMS Market, by Component

  • Software
  • Services

Global CTMS Market, by Region

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Product Analysis:

  • Product matrix, which gives a detailed comparison of the product portfolios of each company

Geographic Analysis:

  • Further breakdown of the North American CTMS market into U.S. and Canada
  • Further breakdown of the Europe CTMS market into Germany, U.K., France, and Rest of Europe
  • Further breakdown of the APAC CTMS market into Japan, China, India, and Rest of APAC
  • Rest of the World CTMS market into Latin America, Middle East, and Africa

Company Information:

  • Detailed analysis and profiling of additional market players (Up to 5)

Table of Contents

1 Introduction
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Markets Covered
    1.4 Geographic Scope
    1.5 Years Considered for the Study
    1.6 Market Segmentation

2 Research Methodology
    2.1 Research Design
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Secondary Sources
    2.2 Market Size Estimation
           2.2.1 Market Size Estimation Steps
           2.2.2 End-User Analysis
           2.2.3 Bottom-Up Approach
           2.2.4 Top-Up Approach
           2.2.5 Primary Research – Sampling Frame
    2.3 Data Triangulation and Research Assumptions

3 Executive Summary
    3.1 Introduction
    3.2 CTMS Market, By End-User (2016)
    3.3 CTMS Market, By Delivery Mode, 2016 vs 2021
    3.4 CTMS Market Share, By Type, 2016
    3.5 CTMS Market Share, By Component, 2016 
    3.6 CTMS Market, By Geography 
    3.7 Competitive Landscape

4 Premium Insights
    4.1 Market Opportunities for Growth in CTMS Market (2016-2021)
    4.2 Asia-Pacific to Lead the Market Growth for CTMS During the Forecast Period
    4.3 Global CTMS Market, By End-User and Mode of Delivery (2016) 
    4.4 Global CTMS Market, By Component and Type, 2016 vs 2021 

5 Market Dynamics
    5.1 Overview
    5.2 Key Market Drivers
           5.2.1 Rising R&D Expenditure of Pharmaceutical, Life Science and Clinical Research Industries
           5.2.2 Rising Number of Clinical Trials
           5.2.3 New Product Launches
           5.2.4 Increasing Customer Base Owing to Adoption of CTMS Solutions
           5.2.5 Rising Adoption of CTMS Due to Advantages Provided By It
    5.3 Key Market Restraints
           5.3.1 Budget Constraints
           5.3.2 Lack of Skilled Professionals
    5.4 Key Market Opportunities
           5.4.1 Increasing Outsourcing of Clinical Trials to Cros in Asian Countries
           5.4.2 Use of Platform-As-A-Service (PaaS) Platform and Mobile Computing
    5.5 Key Market Trends
           5.5.1 Collaborative Ctms: Integration of CTMS With Other Software Such as His, Emr and Edc

6 CTMS Market, By End-User
    6.1 Overview
    6.2 Pharmaceutical and Biopharmaceutical Companies 
    6.3 Contract Research Organizations
    6.4 Medical Device Companies
    6.5 Others

7 CTMS Market, By Delivery Mode
    7.1 Overview
    7.2 Web-Based (Hosted) CTMS 
    7.3 Licensed Enterprise (On Premise) CTMS
    7.4 Cloud-Based (SaaS) CTMS

8 CTMS Market, By Component
    8.1 Overview
    8.2 Software 
    8.3 Services 

9 CTMS Market, By Component
    9.1 Overview
    9.2 Enterprise CTMS 
    9.3 Site CTMS

10 Geographic Analysis
     10.1 Overview
     10.2 North America
             10.2.1 Significant Number of Ongoing Clinical Trials in the Region
             10.2.2 Rising Government Support for Clinical Trial
     10.3 Europe
             10.3.1 Government Support
             10.3.2 Growing Biosimilars Market Key Driver of Clinical Activities in Europe
     10.4 Asia-Pacific
             10.4.1 Increasing Number of Clinical Trials in the Region
             10.4.2 Government Initiatives in the Region
     10.5 Rest of the World 
             10.5.1 Favorable Clinical Trials Regulation in Brazil and Mexico
             10.5.2 Investment in Middle East

11 Competitive Intelligence
     11.1 Global CTMS Solutions Market Share, By Key Player, 2015
     11.2 Competitive Profile Matrix – Top Three Players
     11.3 Competitive Situation and Trends

12 Company Profiles and Analysis
     12.1 Overview
     12.2 Oracle Corporation
     12.3 Medidata Solutions, Inc.
     12.4 Parexel International Corporation
     12.5 Bioclinica, Inc.
     12.6 Bio-Optronics, Inc.
     12.7 Merge Healthcare Incorporated (An IBM Company)
     12.8 Datatrak International, Inc. 
     12.9 Veeva Systems, Inc.
     12.10 DSG Inc. (Document Solutions Group) 
     12.11 Eclinforce, Inc. 
     12.12 ERT
     12.13 Forte Research Systems, Inc.
     12.14 Mednet Solutions, Inc.

13 Appendix
     13.1 Discussion Guide
     13.2 Introducing RT: Real-Time Market Intelligence
     13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal 
     13.4 Available Customizations
     13.5 Related Reports 


List of Table (34 Tables)

Table 1 Impact Analysis: Drivers
Table 2 Impact Analysis: Restraints
Table 3 CTMS Market Size, By End User, 2014-2021 (USD Million)
Table 4 CTMS Market Size for Pharma and Biopharma Industry, By Region, 2014-2021 (USD Million)
Table 5 CTMS Market Size for Contract Research Organizations (Cro), By Region, 2014-2021 (USD Million)
Table 6 CTMS Market Size for Medical Device Manufacturers, By Region, 2014-2021 (USD Million)
Table 7 CTMS Market Size for Others, By Region, 2014-2021 (USD Million)
Table 8 Global CTMS Market Size, By Mode of Delivery, 2014–2021 (USD Million)
Table 9 Web-Hosted (On-Demand) CTMS Market Size, By Geography, 2014–2021 (USD Million)
Table 10 Licensed Enterprise (On-Premise) CTMS Market Size, By Geography, 2014–2021 (USD Million)
Table 11 Cloud-Based (SaaS) Market Size, By Geography, 2014–2021 (USD Million)
Table 12 Global CTMS Market Size, By Component, 2014–2021 (USD Million)
Table 13 Software Market Size, By Geography, 2014–2021 (USD Million)
Table 14 Services Market Size, By Geography, 2014–2021 (USD Million)
Table 15 Global CTMS Market Size, By Type, 2014–2021 (USD Million)
Table 16 Enterprise CTMS Market Size, By Geography, 2014–2021 (USD Million)
Table 17 Site CTMS Market Size, By Geography, 2014–2021 (USD Million)
Table 18 CTMS Market Size, By Geography, 2014–2021 (USD Million)
Table 19 North America: CTMS Market, By End-User, 2016-2021 (USD Million)
Table 20 North America: CTMS Market, By Type, 2016-2021 (USD Million)
Table 21 North America: CTMS Market, By Delivery Mode, 2016-2021 (USD Million)
Table 22 North America: CTMS Market, By Component, 2016-2021 (USD Million)
Table 23 Europe: Market, By End-User, 2016-2021 (USD Million)
Table 24 Europe: Market, By Type, 2016-2021 (USD Million)
Table 25 Europe: Market, By Delivery Mode, 2016-2021 (USD Million)
Table 26 Europe: Market, By Component, 2016-2021 (USD Million)
Table 27 APAC: Market, By End-User, 2016-2021 (USD Million)
Table 28 APAC: Market, By Type, 2016-2021 (USD Million)
Table 29 APAC: Market, By Delivery Mode, 2016-2021 (USD Million)
Table 30 APAC: Market, By Component, 2016-2021 (USD Million)
Table 31 RoW: Market, By End-User, 2016-2021 (USD Million)
Table 32 RoW: Market, By Type, 2016-2021 (USD Million)
Table 33 RoW: Market, By Delivery Mode, 2016-2021 (USD Million)
Table 34 RoW: Market, By Component, 2016-2021 (USD Million)


List of Figure (48 Figures)

Figure 1 Clinical Trial Management System Market Share, By End User, 2016
Figure 2 Clinical Trial Management System Market Share By End-User (2016-2021)
Figure 3 R&D Expenditure of Top 10 Pharmaceutical Companies, 2013 vs 2014 (USD Million)
Figure 4 Clinical Trial Management System Market Share for Pharmaceutical & Biopharmaceutical Companies, By Region (2016)
Figure 5 CRO Services Cover the Entire Drug Development Spectrum
Figure 6 Strategic Alliances Between Cros and Pharma Companies (2011-2015)
Figure 7 Clinical Trial Management System Market Share for Contract Research Organizations (CRO), By Region (2016)
Figure 8 Clinical Trial Management System Market Share for Medical Device Companies, By Region (2016)
Figure 9 Clinical Trial Management System Market Share for Other End Users, By Region (2016)
Figure 10 Global Clinical Trial Management System Market Size, By Mode of Delivery (2016)
Figure 11 Web-Hosted (On-Demand) Segment to Dominate the Global CTMS Solutions Market in 2016
Figure 12 Web-Hosted (On-Demand) Clinical Trial Management System Market Share, By Geography (2016)
Figure 13 Licensed Enterprise (On-Premise) Clinical Trial Management System Market Share, By Geography (2016)
Figure 14 Cloud-Based (SaaS) Market Share, By Geography (2016)
Figure 15 Global Clinical Trial Management System Market Size, By Component, 2016 vs 2021
Figure 16 Software Market Share, By Geography (2016)
Figure 17 Services Market Share, By Geography (2016)
Figure 18 Global Clinical Trial Management System Market Share, By Type, 2016 vs 2021
Figure 19 Enterprise Clinical Trial Management System Market Share, By Geography (2016)
Figure 20 Site Clinical Trial Management System Market Share, By Geography (2016)
Figure 21 Clinical Trial Management System Market, By Geography (2016)
Figure 22 Total Number of Ongoing Clinical Trials, By Region (June 2016)
Figure 23 U.S.: Presence of High Number of Organizations From Demand Sidenumber of Biotechnology R&D Organizations, By State (2014)
Figure 24 North America: Clinical Trial Management System Market Share, By End-User(2016)
Figure 25 North America: Clinical Trial Management System Market Share, By Type (2016)
Figure 26 North America: Clinical Trial Management System Market Share, By Delivery Mode (2016)
Figure 27 North America: Clinical Trial Management System Market Share, By Component (2016)
Figure 28 Europe: Pharmaceutical R&D Expenditure, By Country (2012-13), in Terms of USD Million
Figure 29 Europe: Market Share, By End-User(2016)
Figure 30 Europe: Market Share, By Type (2016)
Figure 31 Europe: Market Share, By Delivery Mode (2016)
Figure 32 Europe: Market Share, By Component (2016)
Figure 33 APAC: Market Share, By End-User(2016)
Figure 34 APAC: Market Share, By Type (2016)
Figure 35 APAC: Market Share, By Delivery Mode (2016)
Figure 36 APAC: Market Share, By Component (2016)
Figure 37 RoW: Market Share, By End-User(2016)
Figure 38 RoW: Market Share, By Type (2016)
Figure 39 RoW: Market Share, By Delivery Mode (2016)
Figure 40 RoW: Market Share, By Component (2016)
Figure 41 Competitive Situation and Trends
Figure 42 Geographic Revenue Mix of the Leading Market Players
Figure 43 Oracle Corporation: Company Snapshot
Figure 44 Medidata Solutions, Inc.: Company Snapshot
Figure 45 Parexel International Corporation : Company Snapshot
Figure 46 Merge Healthcare Incorporated : Company Snapshot
Figure 47 Datatrak International, Inc. : Company Snapshot
Figure 48 Veeva Systems, Inc. : Company Snapshot

The global clinical trial management system market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 Million by 2021. The growth in this market is primarily driven by factors such as the increasing adoption of CTMS solutions during clinical trials, growing number of clinical trials, and rising R&D expenditure of pharmaceutical and biopharmaceutical companies.

CTM helps to improve efficiency and reduce the overall cost of conducting clinical trials. It assists companies involved in clinical trial to plan, track, and manage clinical trials and their progress. Moreover, it ensures financial management of the overall clinical trials process.

Based on end users, the clinical trial management system market is categorized into pharmaceutical and biopharmaceutical companies, contract research organizations, medical device companies, and other end users. The pharmaceutical and biopharmaceutical companies segment is expected to account for the largest market share in 2016, primarily due to the increasing R&D expenditure of this segment.

On the basis of delivery mode, the global market is segmented into web-based (on-demand), licensed enterprise (on-premise), and cloud-based (SaaS) segments. The web-based (on-demand) segment is expected to account for the largest market share in 2016, primarily due to benefits provided by the web-based CTMS solution.

On the basis of component, the CTMS market is segmented into software and services. The software segment is expected to account for the largest share of the global clinical trial management system market in 2016, and is also expected to grow at the highest CAGR during the forecast period. This high growth is mainly attributed to the high adoption of the CTMS solution among the end users.

North America is expected to account for the largest share of the market in 2016, followed by Europe. However, the Asia-Pacific market is projected to grow at the highest CAGR during the forecast period. Factors such as increasing outsourcing of clinical trials, availability of large and diverse patient population, presence of less stringent regulatory guidelines as compared to developed nations, and comparatively less cost of conducting clinical trials in APAC countries are stimulating the growth of the market in this region.

Oracle Corporation (U.S.), Medidata Solutions, Inc. (U.S.), and PAREXEL International Corporation (U.S.) were the top players in the CTMS market in 2015. Leading players in the clinical trial management system market primarily adopted the strategies of new product launches and partnerships, agreements, and collaborations to strengthen their product portfolios, expand their customer base, and penetrate into high-growth markets.

Clinical Trial Management Systems Market, CTMS Market

Source: Annual Reports, SEC Filings, Investor Presentations, Press Releases, Journals, Articles, ClinicalTrials.gov, the World Bank, International Federation of Pharmaceutical Manufacturers & Associations, U.S. Food and Drug Administration, National Institutes of Health, the EU Industrial R&D Investment Scoreboard, Expert Interviews, and MarketsandMarkets Analysis

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Healthcare IT Markets on KnowledgeStore
Request Demo